ARCT Research and Charts

ARCT - Arcturus Therapeutics Holdings Inc (Healthcare: Biotechnology)

Projected Earnings Date: 2024-08-12 (Delayed quote data 2025-04-03)

Last 9.49	Change ⇓ -0.71 (-7.01%)	Volume 362,417
	Open 9.59	High 9.78	Low 9.18

8EMA (Daily) 10.84	40EMA (Daily) 13.88	50EMA (Daily) 14.37	STO (Daily) 7.086	MACD Hist (Daily) -0.591
8EMA (Weekly) 13.411	40EMA (Weekly) 18.64	50EMA (Weekly) 19.66	STO (Weekly) 7.905	MACD Hist (Weekly) -1.052


Company Profile
Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on opportunities in rare diseases with a current focus on liver and respiratory diseases. It operates in the segment of research and development of medical applications for nucleic acid-focused technology. The product pipeline of the company includes LUNAR-OTC, LUNAR-CF, and LUNAR-2020.

Disclaimer: All information provided is for informational purposes only and not intended for trading purposes or advice. The quotes and charts are not real time and have delays of at least 20 minutes. Data accuracy cannot be guaranteed as errors will occur. Please do not rely on the above information to make your stock/option trades. Neither OptionChance.com nor any of independent data providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.